SBCM
GILD icon

Silver Bridge Capital Management’s Gilead Sciences GILD Stock Holding History

Silver Bridge Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-7,400
Closed -$379K – 77
2013
Q2 		$379K Buy
+7,400
New +$386K 0.07% 164

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Silver Bridge Capital Management's GILD Position: Q3 2013 in Review

Silver Bridge Capital Management sold out of Gilead Sciences (GILD) in Q3 2013, closing a stake of 7,400 shares — an estimated $379K sold.

Silver Bridge Capital Management first reported a position in GILD in Q2 2013 and held it in 1 quarter. The position peaked at $379K in Q2 2013. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • Silver Bridge Capital Management reported no remaining Gilead Sciences position as of Q3 2013 after selling out during the quarter.
  • Silver Bridge Capital Management sold 7,400 Gilead Sciences shares in Q3 2013, an estimated $379K.
  • Silver Bridge Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 1 quarter.
  • Silver Bridge Capital Management's Gilead Sciences position peaked at $379K in Q2 2013.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on Silver Bridge Capital Management's 13F filing for Q3 2013.